712
Participants
Start Date
November 30, 2025
Primary Completion Date
November 30, 2028
Study Completion Date
November 30, 2028
hMG subcutaneous injection
daily subcutaneous injection
Placebo
daily subcutaneous injection
Lead Sponsor
Granata Bio Corporation
INDUSTRY